PharmAla Biotech Holdings, Inc. (TSE:MDMA)
CNQX:MDMA
Canadian Market
Holding TSE:MDMA?
Track your performance easily

PharmAla Biotech Holdings, Inc. (MDMA) Financial Statements

45 Followers

PharmAla Biotech Holdings, Inc. Financial Overview

PharmAla Biotech Holdings, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.007; its P/E ratio is -11.04; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on December 20, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total RevenueC$ 583.04KC$ 438.67K-C$ 93.33K-
Gross ProfitC$ 290.08KC$ 360.76K-C$ 93.33K-
EBITC$ 36.48KC$ -80.30KC$ -338.74KC$ -72.27KC$ -288.50K
EBITDAC$ 52.27KC$ -67.07KC$ -325.56KC$ -59.09KC$ -275.32K
Net Income Common StockholdersC$ 36.48KC$ -80.30KC$ -338.74KC$ -72.27KC$ -288.50K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 222.85KC$ 195.04KC$ 495.99KC$ 731.72KC$ 730.47K
Total AssetsC$ 2.39MC$ 2.41MC$ 2.27MC$ 2.40MC$ 2.35M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -222.85KC$ -195.04KC$ -495.99KC$ -731.72KC$ -730.47K
Total LiabilitiesC$ 878.00KC$ 1.03MC$ 812.35KC$ 753.89KC$ 693.30K
Stockholders EquityC$ 1.51MC$ 1.38MC$ 1.46MC$ 1.64MC$ 1.66M
Cash Flow-
Free Cash FlowC$ -42.20KC$ -300.95KC$ -545.44KC$ -37.85KC$ -121.67K
Operating Cash FlowC$ 14.32KC$ -31.52KC$ -308.14KC$ 6.85KC$ -1.44K
Investing Cash FlowC$ -56.51KC$ -269.44KC$ -237.30KC$ -44.70KC$ -120.23K
Financing Cash FlowC$ 70.00K-C$ 189.29KC$ 39.10K-
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History

PharmAla Biotech Holdings, Inc. Debt to Assets

PharmAla Biotech Holdings, Inc. Cash Flow

PharmAla Biotech Holdings, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis